AbbVie - Transforming management in SpA: Integrating novel oral approaches in clinical practice.


Industry room 3
English
Satellite Symposia
04 June 2021 17:30 - 19:00

Learning Objective(s): 

  • To discuss the complexity of managing SpA patients and provide an overview on current unmet needs and treatment goals
  • To describe the current SpA treatment paradigm and how this may be transformed with new JAK inhibitors 
  • To distinguish the importance of the JAK-STAT pathway on the pathogenesis of SpA and its key role in both directly and indirectly regulating the production of pro-inflammatory cytokines 
 

Presentations

Title Time Calendar .ics
Management of SpA – Where are we headed?
04 June 2021 17:30 - 17:40 .ics
Deep Dive into PsA: Where do JAK inhibitors fit in?
04 June 2021 17:40 - 18:00 .ics
Deep Dive into AS: Is there a place for JAK inhibitors?
04 June 2021 18:00 - 18:20 .ics
Is the JAK-STAT pathway driving pathogenesis of SpA?
04 June 2021 18:20 - 18:40 .ics
Insightful conclusions
04 June 2021 18:40 - 18:45 .ics
Answers to the questions you are dying to ask!
04 June 2021 18:45 - 19:00 .ics